TATX-21 is a human-derived monoclonal antibody (mAb) that targets ACVRL1/ALK-1. It is applicable for research on atherosclerosis and heart disease. The recommended isotype control for this compound is Human IgG1 kappa, Isotype Control.
Target:
ALK
* VAT and and shipping costs not included. Errors and price changes excepted